aTYR PHARMA (ATYR) Prepaid Assets (2014 - 2026)
aTYR PHARMA's (ATYR) quarterly Prepaid Assets came in at $586000.0 in Q1 2026, down 90.12% YoY from $5.9 million in Q1 2025, and down 13.44% on a QoQ basis from $677000.0 in Q4 2025.
aTYR PHARMA (ATYR) Prepaid Assets (2014 - 2026) Analysis & Trends
aTYR PHARMA (ATYR) has 13 years of Prepaid Assets data on file, last reported at $586000.0 in Q1 2026.
- Quarterly Prepaid Assets fell 90.12% year-over-year to $586000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $586000.0 (down 90.12% YoY) and the FY2025 annual result came in at $677000.0, down 91.63% from the prior year.
- Prepaid Assets retreated to $586000.0 in Q1 2026, from $677000.0 in the prior quarter.
- In the past five years, Prepaid Assets ranged from a high of $10.2 million in Q2 2024 to a low of $586000.0 in Q1 2026.
- A 5-year average of $4.9 million and a median of $4.4 million in 2022 frame the typical range for Prepaid Assets.
- Annual changes were most pronounced in 2024 — Prepaid Assets surged 238.62% — and 2025, when it sank 91.63%.
- Tracing ATYR's Prepaid Assets over 5 years: stood at $2.9 million in 2022, then retreated by 18.98% to $2.4 million in 2023, then surged by 238.62% to $8.1 million in 2024, then slumped by 91.63% to $677000.0 in 2025, then fell by 13.44% to $586000.0 in 2026.
- The last three Prepaid Assets figures came in at $586000.0 (Q1 2026), $677000.0 (Q4 2025), and $1.8 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | aTYR PHARMA | 49.54 Mn | -7.87 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 518,000.00 |
| Mar 31, 2026 | 586,000.00 |
| Dec 31, 2025 | 677,000.00 |
| Sep 30, 2025 | 1.77 Mn |
| Jun 30, 2025 | 6.65 Mn |
| Mar 31, 2025 | 5.93 Mn |
| Dec 31, 2024 | 8.09 Mn |
| Sep 30, 2024 | 8.50 Mn |
| Jun 30, 2024 | 10.19 Mn |
| Mar 31, 2024 | 9.94 Mn |
| Dec 31, 2023 | 2.39 Mn |
| Sep 30, 2023 | 3.08 Mn |
| Jun 30, 2023 | 4.56 Mn |
| Mar 31, 2023 | 3.44 Mn |
| Dec 31, 2022 | 2.95 Mn |
| Sep 30, 2022 | 6.39 Mn |
| Jun 30, 2022 | 4.38 Mn |
| Mar 31, 2022 | 4.03 Mn |
| Dec 31, 2021 | 5.22 Mn |
| Sep 30, 2021 | 5.09 Mn |